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Davis Kibirige*, Solomon Kibudde and Edrisa MutebiAbstract
Background: Fibrocalculous pancreatic diabetes is an infrequent type of secondary diabetes due to chronic tropical
non alcoholic calcific pancreatitis. It has been widely described exclusively in developing tropical countries. A
diagnosis is made basing on the presence of abdominal pain, presence of pancreatic calcifications, steatorrhoea,
and diabetes mellitus.
Case presentation: We report a case of a 20 year old Ugandan female patient who presented with features of
chronic tropical calcific pancreatitis complicated by diabetes mellitus, oedematous malnutrition and micronutrient
deficiencies.
Conclusion: This case report demonstrates that fibrocalculous pancreatic diabetes still exists in developing
countries like Uganda. Clinicians in such settings should possess a high clinical suspicion of fibrocalculous
pancreatic diabetes especially in presence of malnutrition. Challenges of management of such patients in resource
limited settings are comprehensively discussed in the review of literature.
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In addition to the classical type 1 and type 2 forms of
diabetes, other rare forms of diabetes mellitus (DM) like
fibrocalculous pancreatic diabetes (FPD) have been
described and still exist in SSA [1].
Tropical calcific pancreatitis (TCP) is a juvenile form
of chronic calcific, non alcoholic pancreatitis highly
prevalent in developing and tropical countries. It is often
associated with pancreatic exocrine and endocrine dys-
function. With occurrence of DM, it is referred to as
FPD. It develops as a late complication of TCP and it is
often very severe [2].
Several cases reports of FPD have been extensively
described in literature from tropical, poverty stricken Af-
rican [3,4] and Asian [5,6] countries for over 50 years.* Correspondence: davouirek@yahoo.co.uk
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A 20 year old female patient was referred from a rural
hospital to the endocrine unit with a three year history
of generalised body weakness associated with progressive
weight loss and recurrent generalised abdominal pain.
She also had a five month history of polydipsia, polyuria
and a day’s history of high grade fever with dysuria. She
had no history of steatorrhoea.
Prior to her referral, she was being treated as a patient
with type 1 DM for 4 months in a rural hospital. She
also received analgesics and multi vitamins as treatment
for the generalised abdominal pain and body weakness
respectively. However, due to inadequate resources at
that rural hospital, no specific clinical investigation was
done to determine the cause of her recurrent abdominal
pain. Her HIV serology was negative.
She was the 5th child of seven and all her siblings were
healthy. There was no familial history of diabetes. She
had no history of alcohol ingestion. Her diet since child-
hood was predominantly rich in carbohydrates.
Physical examination revealed a young lady with a low
body mass index of 15.8kg/m2. She had sparse silky hairLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Kibirige et al. BMC Research Notes 2012, 5:622 Page 2 of 3
http://www.biomedcentral.com/1756-0500/5/622with bilateral cataracts, mild pallor of the mucous mem-
branes, atrophic glossitis, leuconychia and bilateral pedal
oedema. No skin changes or any bleeding tendencies
were noted.
On the neurological examination, she was fully con-
scious but appeared apathetic. She had a slow thought
process and poor short-term memory. Deep tendon
reflexes, joint position and vibration senses were not
assessesed because the patient was very unco-operative.
Musculoskeletal examination revealed generalised
muscle atrophy with tenderness of the bones and over
the spine vertebrae.
At presentation to the endocrine unit, the haemato-
logical investigations done included a raised random
blood sugar level of 26.7 mmol/l (normal: 3.5-7.7). The
complete blood count showed a leucocytosis of 21,900/
mm3 (normal: 4,000-10,000), mild normocytic normo-
chromic anemia of 10.8 g/dl (normal: 12–16) and a
thrombocytopenia of 60,000/mm3 (normal: 150,000-
400,000). She had severe hypoalbuminemia of 18.9g/dl
(normal: 35–50) and a corrected hypocalcaemia of 7.2
mg/dl (normal: 9–10.5 mg/dl). The serum vitamin B12
levels were reduced (128.9 pg/ml [normal range: 204–
900]). The lipid profile, renal and liver function tests
were normal. The urinalysis showed glycosuria, numer-
ous pus cells, mild proteinuria but no ketonuria. The
stool analysis revealed no fat globules, ova and cysts.
However, this was done without prior fat loading.
Assessment of the glycated haemoglobin (HbA1c) and
fasting C-peptide levels were not done because of the
high costs involved and were unavailable at the hospital
at the time of the patient’s admission.
The abdominal X-ray showed multiple pancreatic cal-
cifications (Figure 1). An abdominal ultrasound scan
showed diffuse calcifications in the head, body, and tail
of the pancreas.Figure 1 Erect plain X-ray showing pancreatic calcifications. The
arrows illustrate the calcifications in the pancreatic region.A diagnosis of FPD with severe oedematous malnutri-
tion and micronutrient deficiency complicated by a uro-
logical sepsis was made.
The patient achieved good glycemic control on pre-
mixed insulin (Mixtard) in small doses of 10IU pre
breakfast and 5IU pre supper. She also received pancre-
atic enzyme granules given with meals and the co-
existing micro nutrient deficiencies were corrected with
vitamin A, D, B12 and calcium replacement. The urinary
tract infection was treated with oral ciprofloxacin.
She was adequately counselled on the features of both
hypoglycemia and hyperglycemia since she could not af-
ford a glucometer to do regular self blood glucose moni-
toring. She also received dietary counselling with
emphasis on a high protein diet. She was discharged
when she had greatly improved. All serial fasting blood
glucose levels done prior to discharge were within the
normal ranges. Unfortunately, she has been lost to
follow-up because she could not afford the transport
costs needed for the clinic reviews.
Discussion
In this case report, we report a case of a young African
patient presenting with clinical features of FPD. Similar
presentation has been described in the documented
cases reported in other parts of Africa [3,4] and Asia
[5,6].
The classical recognised clinical picture of FPD is pri-
marily of a young diabetic patient presenting with recur-
rent epigastric pain, steatorrhoea, signs of malnutrition
and micro nutrient deficiencies. Steatorrhoea is however,
relatively rare especially in areas with low dietary fat in-
take [7] as demonstrated in this case report.
Multiple factors have been thought to be associated
with FPD. These include malnutrition; toxic effects of
cyanide derived from frequent cassava consumption, fa-
milial aggregation, genetic factors and increased oxidant
stress from micronutrient deficiency (vitamin C and A
deficiencies) [7,8].
However, several recent reports have disputed the the-
ories that malnutrition and frequent cassava ingestion
have aetiological roles in FCP. Studies from certain
regions of the world with very high frequencies of mal-
nutrition like Ethiopia have documented a relatively low
frequency of FCP [9]. A study by Swai et al. compared
two rural Tanzanian populations of which one had cas-
sava as the staple food and also elevated urinary and
plasma cyanide levels and noted no significant difference
in glucose tolerance or magnitude of DM [10].
Genetic factors have been proposed as the most sig-
nificant in the aetiology of FCP. Current evidence has
confirmed a link between the serine protease inhibitor,
Kazal type 1 (SPINK 1) gene and TCP [11,12]. It is a
vital protease inhibitor that prevents unregulated or
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cade by inhibiting trypsin activity [13]. This would even-
tually result into recurrent pancreatitis.
Demonstration of hyperglycemia and pancreatic calculi
on plain abdominal X ray, abdominal computed tomog-
raphy scan or ultrasound scan confirms the diagnosis as
shown in the patient discussed [14].
Patients with FCP usually require treatment with insu-
lin though in small quantities. This is due to the pres-
ence of residual beta cell function reflected by the
intermediate C- peptide levels among these patients
[15]. As demonstrated in the case report, ketosis among
patients with FPD is very infrequent. This is because of
the residual pancreatic beta-cell reserve, a low glucagon
reserve and decreased adipose tissue mass [15].
The main challenge involved in the management of
patients with FPD in resource limited countries is recur-
rent episodes of hypoglycemia. This is due to the partial
preservation of the pancreatic beta cell mass and func-
tion and lack of continuous self monitoring of blood
glucose among these patients because of related costs
involved. This results into increased morbidity and
mortality. Delayed or misdiagnosis of the cases, inad-
equate diabetic medicines especially insulin, protracted
micronutrient deficiencies and inability to adequately
correct micro and macro nutrient deficiency are also
other management challenges.
Conclusion
FPD still exists in developing countries. An active
approach in recognising such cases should be adopted in
these settings. Conservative glycemic control, frequent
blood glucose monitoring and correction of the micro
and macronutrient deficiencies are very fundamental in
the management of patients with FPD and should be
strongly emphasised.
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